Ross River virus, an Australian group A arbovirus, was adapted by serial passage to cell cultures and to day old mice. The results of titrations in mice of different ages allowed the comparison of virulence between different stocks. Passage in cell cultures depressed the virulence of virus while passage in mice raised the level of virulence. Clones of original virus populations revealed heterogeneity with respect to virulence but none of the 4I clones was as highly virulent as virus passed Io times in mice. Clones selected in sequence during serial passage in mice indicated that adaptation proceeded by the overgrowth of variants of increasingly higher virulence, and that clones from relatively highly passaged strains were still heterogeneous in virulence.
INTRODUCTION
The recovery of viruses from either field or pathological samples frequently involves an adaptation of the agent to a suitable laboratory host. At times several serial passages may be needed to establish evidence of isolation or to raise pathogenicity for animals or cells to levels considered necessary for laboratory experimentation. Bradish, Allner & Maber (1971) have commented on the importance of alterations in virulence, protective properties and virus population changes that may occur even within very few animal passages, but scant attention is usually given to the original characteristics of an isolate and its integrity in the passaged variant finally studied. Recent reports from this laboratory Murphy et al. I973) indicate that important pathological events may be overlooked by using fast growing, adapted virus stocks.
Adaptation to a novel environment, either in the laboratory or the field, implies a mechanism for variation, usually ascribed to random mutation or selection of variants (Fenner & Cairns, 1959) ; with the arboviruses neither host induced variation (Hoskins, 1959) nor genetic recombination (Burge & Pfefferkorn, 1966) has been demonstrated convincingly. Constant exposure to a selection pressure ensures that the variant best suited to the system predominates. Adaptation has been shown to proceed by the selection of a pre-existing minority population (II'Enko et al. I968) or by the selection of de novo mutants arising during the course of replication in the new host (Churchill, Chubb & Baxendale, 1969) .
The availability of unmanipulated pools of Ross River virus (RRV), an Australian group A arbovirus (Doherty et al. I963) , and the alteration in pathogenicity observed during serial passage in infant mouse brain (Gard, Marshall & Woodroofe, 1973) prompted a more * Present address: Federal Department of Veterinary Research, Vom, Benue Plateau State, Nigeria. detailed investigation of the processes underlying adaptation, the results of which are reported here and in an accompanying paper (Taylor & Marshall, I975) .
METHODS
Viruses. Strains of RRV with the prefix NB were recovered from pools of Aedes vigilax mosquitoes or Mansonia linealis (Gard et al. 1973) collected at Nelson Bay on the central coast of New South Wales.
Strain NB5o92 was used as the original field mosquito pool (NB5o92/field), after one or I2 passages in infant mouse brain (MB), (NB5o92/MB[ ; NB5o92/MBI2), as the fifth Vero cell passage from NB5o92/MBI (NB5o92/MBI/Vero-5), or as virus maintained for five alternating passages between infant mice and laboratory reared Aedes aegypti mosquitoes (MOS) (NB5o92/MB 3 MOS2).
Strains NB6o24 and NB7t 13 were used as the original infected mosquito pools (NB6o24[ field; NB7II3/field) while NB6o M was also used after one infant mouse brain passage (NB6o24/MBt).
The prototype RRV strain T48 (Doherty et al. 1963) , was used after 12 passages in infant mouse brain (T48/MBI2).
Procedures involving cell cultures. Plaque assays of virus infectivity were made in triplicate using Vero cell monolayers inoculated with o-I ml samples from a tenfold dilution series prepared in chilled borate-buffered gelatine saline, pH 7"2 (Fazekas de St. Groth, Graham & Jack, I958). Plaques were counted after the addition of neutral red counterstain following incubation for four days at 35"5 +-o'5 °C under tris buffered agar overlay; virus infectivities are expressed as p.f.u./ml or p.f.u./g. Clones were obtained from NB5o92]MBI, NB5o92/MBI2, NB6o24[field or from stocks prepared during the serial passage of NB6o24[field. In each case virus was obtained by aspirating the agar and underlying cell debris from well developed plaques on monolayers of Vero cells. Homogeneity of the selected variant was indicated by one or two cycles of replating, harvesting only from monolayers bearing single plaques. Final stocks of selected clones of virus were grown in the same cell type held under fluid maintenance medium until c.p.e, was apparent. Cell-associated virus was released by freezing and thawing and the suspension clarified by centrifuging at low speed.
Tissue harvests. Mouse brains were aspirated into glass ampoules with a suction apparatus without opening the cranium. Mouse carcases (MC), or parts thereof, were obtained by the removal of the head, skin and viscera of exsanguinated mice. All stocks were prepared at IO ~ w/v suspensions in normal saline.
Estimation of virus infectivity and virulence in experimental mice. An outbred multicoloured line of Walter and Eliza Hall Institute mice was used throughout. The age of experimental animals was an important feature of this work and group allocations were as follows: 'day old' mice were used during the first 24 h of life, 'infant mice' were not older than 48 h, while ' one week' old mice had completed seven but not eight full days of life. Older age groups were obtained by holding mice for discrete increments of I week.
For titrations of virus infectivity, o.o2 ml samples of dilutions prepared as above were inoculated i.c., i.p., or s.c. into mice of defined age, using eight titter-mates per dilution and a 0.o2 ml inoculum. The incidence of clinical signs and mortality in infected litters was recorded daily for 2 weeks.
Certain combinations of virus and age group of mice were characterized by almost benign or entirely subclinical infections. For this reason, the end point of all virus titrations was determined by the challenge of mice surviving to the I4th day. Mice first used as infants or day olds were inoculated i.p. with lO 6.o day old mouse LDso of a mouse adapted stock (T48/MBI2), and held for a further IO days for development of pathognomonic signs. The absence of clinical signs was taken as evidence of prior infection. With RRV, however, there is an age-dependant resistance to the development of clinical signs so that an alternative system was required for mice first used when I week old or older. These animals were challenged as above, bled 48 h later, and individual samples screened for viraemia in a cellculture assay. It was established that susceptible mice between 3 and 8 weeks old had peak viraemia of Io 3.4 to 1o 6.3 p.f.u./ml at 48 h, and that the absence of detectable viraemia at this time indicated the presence of antibodies to RRV detectable by haemagglutination inhibition (HI). For each virus stock examined in mice, infectivities were calculated as 50 % end points (Reed & Muench, I938) to show the total infectivity (IDs0/ml or IDs0/g), infectivity in terms of clinical signs (CDso/ml or CDs0/g ) and, where appropriate, infectivity based on mortality (LDso/ml or LDs0/g ). Morbidity and mortality rates, obtained from the same samples, indicate the % of infected animals that developed either clinical signs or died. Average survival times (AST) represent the arithmetic mean for all mice dying during the course of a titration regardless of dose, since for most strains of RRV the death times are independent of dose. The mouse virulence of each RRV stock was assessed using these parameters, although it is realised that conclusions may only be valid for this particular model system.
RESULTS

The responses of mice to unadapted NB strains of RRV
The severity of RRV infection in laboratory mice depends on the origin and treatment of the strain used, and the age of the indicator host. Between extremes of subclinical and rapidly lethal infections, a distinctive intermediate syndrome is seen (Mims et al. I973) , characterized by various degrees of hind limb paralysis from which the infected mice frequently recover. Murphy et al. 0973) have described the necrosis of striate muscle which underlies this clinical sign. Two field isolates in processed mosquito pools, NB5o92/field and NB7I I3/field, were titrated by i.e. inoculation in day old mice to give results that typify this mild syndrome (Table I) .
Such unadapted field strains produced clinical signs in the majority of infected day old mice (86 to ioo ~) after an incubation period of 5 to 6 days, but the mortality rate (5 to 24 ~o) was too low to allow an LDs0 end point. Deaths occurred during the second week of infection amongst the most severely paralysed mice. Recovery was frequently complete by day 14 although in some mice residual signs persisted for up to a further IO days, accompanied at times by severe wasting of muscle. * log (IDs0/ml). t log (LDs0/ml).
Comparative titrations by different routes of inoculation
Alternating passage in infant mice and mosquitoes does not alter the virulence of field strains of RRV (Taylor & Marshall, 1975) , but passage in infant mice produce an increase in virulence (vide infra). To compare the influence of route of inoculation, a mouse brain adapted stock NB5o92/MB~/, and a stock maintained by alternate mouse and mosquito passage, NB5o92/MB3 MOS2, were used. Parallel titrations in infant mice were made with each stock inoculated i.c., i.p., or s.c. (Table z) .
The infectivities for NB5o92/MB3 MOSz were similar for all inoculation routes. The morbidity of over 93 ~ reflected a small number of subclinical infections but mortality rates were never above 2i ~. Most deaths occurred in the group inoculated i.p., although other experiments with RRV strains of different virulence have not shown that infection by the i.p. route is more lethal than that by the i.c. or s.c. routes. On the basis of the response to i.c. infection virus stock NB5o92[MB3 MOS2 is similar to the field pools NB5o9z or NB7I 13 (Table I) .
On the other hand, mice inoculated by any route with the mouse-adapted NB5o92]MBI2 strain invariably died within 5 to 7 days, but, again, differences in infectivity were not evident.
When 3-week old mice were infected i.e. or i.p. with the same virus stock of strain NB5o92/ MB3 MOS2, infectivities were io 3'5 and io 3"7 IDs0/ml respectively, although all infections were benign. It was concluded therefore, that route of inoculation did not influence significantly the outcome of RRV infections in laboratory mice.
Alterations in virulence with passage in cell cultures
Before cell culture passage, the virulence of clone 62 was typical of a group of clones isolated from NB6o24/field (vide infra) each of which produced frank clinical signs in all infected day old mice and sufficient mortality (20 to 60 ~) to allow the calculation of an LDso end point. This level of virulence was slightly higher than that of isolates NB5o92/field and NB7I I3/field (see Table I ). In contrast, clone 64 from the same material was clearly more virulent and invariably killed all the day old mice it infected.
These clones were passaged eight times in monolayers of Vero cells and the virulence examined by i.c. inoculation of day old mice at passages I, 4 and 8 (Table 3) .
Both clones were less virulent for mice after passage in Vero ceils. Clone 62 showed a steadily declining mortality rate, from 5o ~ with the original stock, to 8 ~ after 8 passages and at this latter level some infections were now subclinical. Essentially similar results were Similar manipulations were made with two other stocks of virulent virus previously adapted by passage in mouse brain, (NB5o9z/MBIz and T48/MBI2 ). Of these, T48/MBI2 was more virulent since it caused 7o ~ of deaths in 3 week old mice, whereas NB5o92/MBI2 was unable to produce clinical infections, let alone deaths, in mice of this age. Titrations in I-week old mice (Table 4) indicated that NB5o92/MBI2 declined in virulence between Veto passages 2 and 8, since the survival time increased (P < o-oot) and the mortality rate declined. For virus strain T48/MB 12, although mortality was little affected in I-week old mice, the longer survival was again a feature of passage (P < o.ooI ; Table 4 ). In 2-and 3-week old mice there was a significant reduction in morbidity and mortality rates. Thus virus strain T48/MBI2]Vero-I was significantly less virulent after 7 further passages in Vero cells.
The similar passage of virus strains in monolayers of BHK cells yielded different results. Over eight passages there was no indication of the attenuation of clone 62, NB5o92/MBI or NB6o24/MBI. However there was a decline in the virulence of c/one 64, with the morbidity in one day old mice falling from IOO ~ to 75 ~ and mortality from IOO ~ to 53 ~o after 8 passages in BHK cells.
Thus the passage of RRV strains in cultures of some cells may select variants of reduced virulence, although this is not a regular effect. 
Passage level Fig. I . The adaptation to mice of RRV strain NB6o24 by serial passage in day old mice. The first passage (MBI) was from the brain of a day old mouse infected i.c. with a terminal dilution of the field mosquito pool NB6oz4. Subsequent passages were with high doses inoculated s.c. of virus prepared from a mouse carcase (MC) from the previous passage. The histogram shows increasing morbidity and mortality rates in mice of given ages infected with virus strains at increasing passage levels. The upper graph is of the mean survival times (+s.e.) of day old mice infected with virus strains at given passage levels.
Alterations in virulence with passage in day oM mice
A sample of the mosquito pool NB6o24[field was titrated by i.c. inoculation in day old mice, and by clinical signs the terminal dilution appeared to be at lO -3 . The brains of all mice inoculated with the lO -3 and IO -4 dilutions were collected individually at day 7 and tested for virus. Three of 7 brains inoculated with the I o -z dilution contained virus, and none of 8 inoculated with Io -4. Virulence assays indicated that the 3 mouse brain stocks collected from the terminal dilution were similar to each other and to the majority of RRV strain NB6o24 clones derived from plaques on Vero cells. As the 3 strains appeared to behave similarly during two further passages in mice, the adaptation series was continued with only one line.
After the initial selection by terminal dilution, all transfers were made with the highest dose practicable in order to enhance transmission of variants of higher virulence. The first passage was by mouse brain (MB) harvest after i.c. inoculation, but all subsequent transfers were by s.c. inoculation to be more comparable to alternate mosquito-mouse passage experiments reported elsewhere (Taylor & Marshall, I975) and, as it was now appreciated that RRV is myotropic (Murphy et al. I973) , virus for further passage was recovered from mouse carcase (MC). In effect, transfers were usually at a i : io dilution of IO ~o carcase suspension, which in early transfers represented a dose of about io ~ IDs0/mouse, and up to Mortality in day old mice increased rapidly from the initial 39 ~ and all died when inoculated with NB6o24/MBI/MC2 and subsequent passage strains (Fig. I) . AST decreased from i I days for NB6o24/MBI until it reached 4 to 5 days for MBI/MC8. NB6o24/MBI failed to produce morbidity or mortality in 1-week old mice, but morbidity was IOO 9/oo for MB I/MC2, and all mice of this age died when inoculated with MB I/MC6 and higher passage strains. The AST was again shortened by MBI/MC8, the initial death time of 12 to I4 days decreasing to 7 to 8 days. Similarly, the proportion of 2-week old mice that recovered fell between passage levels 6 and 9, and when inoculated with MBI/MC9 and subsequent passage strains all mice showed clinical signs and lOO ~ mortality. In 3-week old mice mortality fluctuated between 40 ~ and 60 ~ for all passage levels after MBI/MC8, but in 4-week old mice morbidity did not reach more than about 5o ~ and mortality was less than 20 ~. Virulence for laboratory mice assessed by these observations of the morbidity, mortality, AST and infectivity in mice of different age groups did not increase significantly beyond passage strain NB6o24/MBI/MC9.
The evidence of rising virulence associated with passage in mice was open to interpretation in two ways. Either the starting material (NB6o24/field) contained one or more highly virulent sub-populations, the proportion of which rose during passage, or, during the course of serial transmission, one or more virulence mutations occurred again followed by enrichment. Bearing in mind that the passage series described was established by a terminal dilution we favoured the latter interpretation. Nevertheless further evidence was sought by examining the virulence of field material in more detail, by inoculating mice with known mixtures of virulent and avirulent viruses and finally by experiments with mouse passaged virus.
Characterization of clones from fieM isolations of virus
A total of 3o clones were selected from a range of dilutions of RRV strain NB5o92]MBI, and of these I5 were examined by i.c. and s.c. inoculation of lO 4 p.f.u, of the clone stock into groups of 6o to 7o infant mice. By this technique I4 clones were reasonably homogeneous, having a mean i.c. mortality rate of 24 ~. One, clone 3, was apparently more virulent, with an i.c. mortality of 77 ~-There was no relationship between the pathogenicity of any clone and the route of inoculation.
To elucidate the relationship between mortality and virus dose, 7 clones were titrated by i.c. inoculation in infant mice at dilutions down to Io -7 (Table 5) . Morbidity rates were always high but, with the exception of clone 3, mortality rates were low (mean 6 ~ in total of 3o5 infected mice). In this experiment clone 3 had a mortality rate of 62 ~ and an LDs0 of Io~'S/ml. Aside from clone 3, pooled data showed that for virus dilutions from Io ° to Io -7 the number of deaths per number of mice infected at each dilution were 3/48, 6/48, 1/48, 4[48, o/48, ~/4t, x/i8 and 2/6. As the probability of a fatal outcome did not vary with virus dose, LDs0 estimates could rarely be made with this type of virus. In a final test, each of the 3o NB5o9z/MB I clones was inoculated i.p. into x-week old mice at a fixed high dose. Transient clinical signs were produced by 9 clones but only clone 3 gave macroscopic evidence of muscle necrosis at post-mortem.
A further I I clones were selected at random from a sample of NB6o24[field which had been diluted zoo-fold and plated in its entirety. Titrations performed by i.c. inoculation of infant mice differentiated one clone of relatively high virulence, clone 64, from the remaining 'background' group (Table 6 ). Confirmation of exalted virulence was obtained in x-week mice, in which clone 64 gave the highest morbidity and was unique in its ability to kill (I7"5 ~ mortality).
A simultaneous comparison by titration of clones derived from NB5o9z/MBr and NB6oz4/field in more accurately aged (day old) mice allowed the following deductions: background NB6oz4 clones were slightly more virulent than their counterparts from NB5o92]MBI, with mean mortalities of 6o and 27 ~ respectively, and also, because of a dose response, regularly gave LDs0 end points in day old mice. Clone 3 (NB5o92) in these mice was indistinguishable from NB6oz4 background clones, while clone 64 remained the most virulent virus found in unadapted material and regularly caused Ioo ~o mortality in day old mice.
These experiments, although indicating sub-population heterogeneity, failed to identify a virus in unadapted field material equivalent in virulence to that present in highly mouseadapted stocks.
Inoculation of mice and cell cultures with mixtures of virulent and avirulent viruses
Following the demonstration that field virus contained sub-populations of strains of different virulence for mice, experiments were carried out to determine the interaction of pre-determined strains when inoculated as mixtures into mice or cell cultures. A small plaquing clone (S0 which killed all day old mice with an AST of about 5 days, and 85 ~ of (Table 7) . With each mixture, the syndrome produced was influenced by each virus. In contrast to the 25 % mortality associated with the avirulent strain, mice inoculated with mixtures invariably died until the ratio of virulent to avirulent virus fell below 1:4oooo, and even at 1:4ooooo the mortality rate was significantly elevated. Yet in each group the presence of the avirulent virus contributec to the outcome by prolonging the survival time, as may be seen by comparing with controls receiving similar doses of SI/NB5o9z[MBI2 only (Table 7) .
Since SI/NB5o92/MBI2 is lower in virulence than the virus strain selected after Io serial mouse passages of NB6o24 (Fig. I) , but is still readily detected even in low doses in the presence of an avirulent partner, it is most unlikely that virus of a highly virulent character exists undetected in unadapted field strains of RRV.
When blood from mice inoculated with the mixtures containing IO 6 and lO 4 virulent to Io 6n avirulent virus was plated on Vero monolayers there were more small than large plaques (virulent S I]NB5o9z/MB I2 gives small plaques relative to avirulent NB5o92[MBI/ Vero-5). Further, the carcase of a mouse harvested 7 days after inoculation with the mixture of ratio Io:~o 6"n virulent to avirulent was processed and the infectivity titrated in day old mice. All infected mice died, but for most comparable dilutions of this material the AST was greater than for SI]NB5o92]MBIz controls ( Table 7 ), indicating that avirulent virus was still present in the harvest. Mice inoculated with Io °'2 LDs0 of the material died with an AST of 4"9 + o-2 days. This survival time was shorter than the 5-6 + o.2 days recorded when SI/NB5o9z[MBIz comprised 25 % of a similar inoculum, (mixture Io°: 1o6"6; Io 7 : Io 6.o 4"8 +o-I 4"3 _+0"3 4-0+0"2 IO 6 : IO 6.6 5"6+0"2 4-6-+0'2 5"2-1-O"1 1o 5 : to ~6 6"3 _+ 0-2 5"o_+ o'o 5"7 _+ 0"3 lO 4 : to ~~ 6'3 _+ o-z 7"5 ---0'3 6"7 _+ 0"4 IO 3 : IO ~~ 9'2_+0"2 9"0_+0'4 8"3+0'3 IC :0 4"0_+0"I 4'7_+O'3 3"7+O'2 8"1 IO0 I00 9"0_+0'2 (P<o'ooI) 2 weeks 7"9 1oo 27 (P<o'oI) 12"3_+o'4 3 weeks 6-2 47 (P<o'o5) o * All values for P are for differences between clones of the same passage level.
Contrasting results were obtained in cell cultures. The first 5 mixtures in the above experiment (Table 7) were inoculated on to Vero monolayers and passed a further four times. At passage levels zero, two and four, undiluted harvests from each input mixture were inoculated into day old mice, all of which died. The AST results are shown in Table 8 . The range of survival times obtained after four passages was not substantially different from that obtained with the unpassaged mixtures, implying that the proportion of viruses in each mixture had remained constant during growth in Vero cells.
Characterization of clones from RRV strain NB6o24 passaged in day old mice
A series of clones was obtained from the plaque assay end points (in Vero cells) with NB6o24 stocks of the first, third, sixth and tenth passage levels in day old mice (Fig. I) . Characterization of virulence was made by titrations in mice of selected ages (Table 9) There was no distinction between clones I/t and I/2 isolated from first mouse brain passage. In spite of a 3oo-fold difference in infectivity neither clone produced ~oo morbidity, and mortality rates of both were low. Clones selected at the third passage, 3/I and 3/2, were both more virulent than I/I or ~/2, as seen by the IOO ~ mortality rates in day old mice. Further, a distinction was possible between 3/i and 3/2; for with 3/2 both morbidity and mortality in I-week mice were significantly higher.
At the sixth passage the two clones selected again differed in virulence, 6/2 being more virulent than 6/1 in terms of AST in day old and I-week old mice, morbidity in 2-week old mice, and mortality in both I-and 2-week old mice. In terms of virulence, clone 6/I appeared identical with the previously isolated clone 3/2.
Clones Io/I and I0/2 could be differentiated by AST in day old and z-week old mice, morbidity in 3-week old mice, and mortality in 2-week old mice, clone Io/I being the more virulent. The only means of distinguishing clones I0/2 from the earlier clone, 6•2, lay in the higher morbidity rate in 2-week old mice found for I0/2 (P < o-oi).
While the differentiation of clones 6/2 and Io/2 was probably not significant, the sum of evidence indicated that as adaptation proceeded stocks retained a sub-population heterogeneity with respect to virulence, and, that the level of virulence of the constituent subpopulations tended to increase with passage.
Replication of RRV clones in 24 h mice
Comparative estimates of virus growth were made by s.c. inoculation of ioo iDs0 of four clones of differing virulence into 4 randomized litters of day old mice. Clones 62 and 64 were from NB6oz4/field (Table 6 ). Clone IO/t was from the Ioth passage stock of NB6o24, (Table 9) , and clone LI was a large plaque-forming variant isolated from NB5o92/MB12 and similar in virulence to the SI clone from the same parent stock (Table 7) . In terms of ascending virulence these clones could be arranged as follows: clone 62, clone 64, clone LI and clone lO/I.
At various intervals two mice from each group were bled and a pool made of the entire hind-quarter musculature. Samples were ground to lO ~ w/v suspensions and titrated on Vero monolayers. Results are shown in Fig. 2 . With each virus a period of exponential growth occupied the first 2o to 30 h, although the rates of growth appeared to follow virulence ranking. The least virulent virus, clone 62, did not increase in titre beyond 30 h and the levels may have declined during the subsequent 66 h. By 72 h all remaining clones had reached peak levels after a period of less rapid growth. Mice infected with clones Io/I and LI did not live beyond this time. Ultimate virus titres retained the same ranking as growth rate and innate virulence.
DISCUSSION
In terms of lethality for adult rabbits, the virulence of strains of myxoma virus was shown to be correlated with the average survival times of the infected rabbits (Fenner & Marshall, 1957) . Attempts to apply these parameters to measure the virulence for mice of strains of RRV derived during selection by passage led to several difficulties. Differences between attenuated strains of RRV can be detected in terms of the survival times of infected newborn mice, but these strains do not kill older mice; highly virulent strains, on the other hand, produce virtually identical average survival times in newborn mice, but can often be readily differentiated by their effects in mice I to 4 weeks old. We therefore titrated RRV strains in groups of mice of different ages and then combined the estimates of infectivity, morbidity, mortality, average survival times and age resistance in these groups to give a comprehensive measure of the relative virulence of the virus strains.
The present experiments clearly identify two selection processes with contrasting effects on RRV during serial passage; cell cultures select for lower virulence in mice, and young mice select for higher virulence. Gard et al. (I973) , in a study of the epizootiology of RRV in the Nelson Bay area, noted an increase in the virulence of NB5o92 during 12 mouse brain transfers. A similar alteration was achieved when the isolate NB6o24 was passaged in the muscle of day old mice. In our adaptation series maximum virulence appeared to be attained in about Io passages. While passage is often terminated when a convenient level of virulence is reached, Smithburn & Haddow (1944) observed increases in virulence when Semliki Forest virus was carried past the 4oth passage in adult mice, and Cole & Wisseman (1969) could distinguish between Dengue virus stocks passaged 33 and I25 times using a combination of suckling and weanling mice. On the other hand, Bradish, Allner & Maber (i 972) using a range of animals as test hosts, and an avirulent strain of SFV, noted a sharp and apparently final increase in the virulence of the virus for mice after only two i.c. passages in weanling hamsters. Adaptation may be more rapid in young than old mice, as Meiklejohn, Stacey & Simpson (1949) found that Dengue virus grew better in the brain of 4 to 6 day old mice than in adults, and Although not examined in depth, the gross similarity in clinical signs and gross pathology, and the growth potential of clone ~ o[I in striated muscle, indicate that muscle passaged virus retains the same tissue tropisms previously described for unadapted virus (NB5o92/MB4 MOS3) and brain passaged virus (T48/MBI2) (Murphy et al. I973) . In view of the predilection shown by RRV for skeletal muscle it was perhaps unrealistic to expect route of passage to influence the character of the adapted virus, although Smithburn 0949) was able to modify Rift Valley fever virus from a pantropic nature when transmitted i.p., to a variant with neurotropic properties when passaged by the i.c. route.
Both NB6oz4/field and NB5o9//MBI may be regarded as unadapted stocks, as both correspond with the normal vertebrate-invertebrate cycles by which arboviruses are maintained in nature. Cloning experiments with these pools indicated the presence of subpopulations of low yet distinct virulence, however it is suggested that the observed alteration in mice did not proceed simply by the selection of a pre-existing virus. Firstly, the NB6oz4 passage series included an initial terminal dilution and, secondly, experiments with mixtures of virulent and avirulent strains of RRV indicated the ease with which a virulent virus could have been detected were it present in unadapted material. From these considerations it appears that sequential increases in virulence during passage in mice depends upon mutational changes occurring during virus replication, and subsequent selection of mutants of successively higher virulence; a process that would be favoured by the high virus inputs employed further to the terminal dilution. Supporting evidence was obtained when clones from successive passage levels were tested and found to be increasingly more virulent, although sub-population heterogeneity was still apparent at any one passage level. Overgrowth by the more virulent mutants appeared to be related to growth characteristics; in infant mouse muscle the more virulent virus strains replicate more rapidly than less virulent, perhaps allowing preferential seeding into the blood stream and secondary replication sites and leading to higher final titres.
While direct experimental evidence was not obtained, it is possible that attenuation for mice during serial passage of RRV in cell cultures is mediated in a similar manner. Certainly Scherer, Ellsworth & Ventura (197 ~) were able to show that the mouse-avirulent TC-83 strain of VEE virus adsorbed and replicated more rapidly in BHK zI cells than the mouse-virulent parent strain of the virus. In our own observations with virus mixtures undergoing passage in Vero cells it was seen that the mouse-virulent partner, although not displaced, gained no selectional advantage in this system. Selection of avirulent variants of RRV during passage was not as consistent or as rapid in BHK21 cells as in Vero cells.
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